What is the address of DR. CHRISTOPHE SCHOONJANS?

The registered office of DR. CHRISTOPHE SCHOONJANS is located at Paallandenstraat 15, 8200 Brugge.

Is DR. CHRISTOPHE SCHOONJANS still active?

Yes. According to the CBE (3 October 2026) DR. CHRISTOPHE SCHOONJANS is active, legal situation “Normale toestand”, started on 22 July 2021.

Is DR. CHRISTOPHE SCHOONJANS registered on Peppol?

Yes, DR. CHRISTOPHE SCHOONJANS is registered on the Peppol network with ID 0208:0771622231.

What is the enterprise number of DR. CHRISTOPHE SCHOONJANS?

The enterprise number of DR. CHRISTOPHE SCHOONJANS is BE0771622231.

When was DR. CHRISTOPHE SCHOONJANS founded?

DR. CHRISTOPHE SCHOONJANS was founded on 22 July 2021.

Who are the directors of DR. CHRISTOPHE SCHOONJANS?

According to the 2025 annual accounts, the directors of DR. CHRISTOPHE SCHOONJANS are: Christophe Schoonjans.

Is DR. CHRISTOPHE SCHOONJANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 July 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. CHRISTOPHE SCHOONJANS make in 2025?

DR. CHRISTOPHE SCHOONJANS posted a profit after taxes of € 178,230 in financial year 2025.

What is the revenue of DR. CHRISTOPHE SCHOONJANS?

As a small company, DR. CHRISTOPHE SCHOONJANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 243,434.

DR. CHRISTOPHE SCHOONJANS (Private Limited) - Brugge

Dossier DR. CHRISTOPHE SCHOONJANS, printed on 3 October 2026 from databakkes.be/en/0771622231/dr-christophe-schoonjans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. CHRISTOPHE SCHOONJANS from Brugge, company number BE0771622231, closed financial year 2025 with a result of € 178,230 after tax. For that financial year DR. CHRISTOPHE SCHOONJANS recorded a gross margin of € 243,434 and equity of € 2,257. Compared with financial year 2024, the result moved from € 96,810 to € 178,230. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.

What it is worth Shrank hard

€ 2,257

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 178,230

▲ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 118,595

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 343,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 32,926

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,338

▼ 71% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,260

▼ 37% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 28,511 Gross margin 2022: € 28,511 First fiscal year in the series	€ 62,908 Gross margin 2023: € 62,908 ▲ 121% vs 2022 (€ 28,511) Favourable step	€ 132,966 Gross margin 2024: € 132,966 ▲ 111% vs 2023 (€ 62,908) Favourable step	€ 243,434 Gross margin 2025: € 243,434 ▲ 83% vs 2024 (€ 132,966) Favourable step	▲ 83%
Profit after taxes	€ 20,673 Profit after taxes 2022: € 20,673 First fiscal year in the series	€ 48,044 Profit after taxes 2023: € 48,044 ▲ 132% vs 2022 (€ 20,673) Favourable step	€ 96,810 Profit after taxes 2024: € 96,810 ▲ 102% vs 2023 (€ 48,044) Favourable step	€ 178,230 Profit after taxes 2025: € 178,230 ▲ 84% vs 2024 (€ 96,810) Favourable step	▲ 84%
Equity	€ 22,173 Equity 2022: € 22,173 First fiscal year in the series	€ 70,218 Equity 2023: € 70,218 ▲ 217% vs 2022 (€ 22,173) Favourable step	€ 167,027 Equity 2024: € 167,027 ▲ 138% vs 2023 (€ 70,218) Favourable step	€ 2,257 Equity 2025: € 2,257 ▼ 99% vs 2024 (€ 167,027) Unfavourable step	▼ 99%
Total debts	€ 7,233 Total debts 2022: € 7,233 First fiscal year in the series	€ 23,555 Total debts 2023: € 23,555 ▲ 226% vs 2022 (€ 7,233) Unfavourable step	€ 39,021 Total debts 2024: € 39,021 ▲ 66% vs 2023 (€ 23,555) Unfavourable step	€ 198,598 Total debts 2025: € 198,598 ▲ € 159,577 vs 2024 (€ 39,021) Unfavourable step	▲ € 159,577
Cash	€ 28,326 Cash 2022: € 28,326 First fiscal year in the series	€ 88,254 Cash 2023: € 88,254 ▲ 212% vs 2022 (€ 28,326) Favourable step	€ 136,291 Cash 2024: € 136,291 ▲ 54% vs 2023 (€ 88,254) Favourable step	€ 118,595 Cash 2025: € 118,595 ▼ 13% vs 2024 (€ 136,291) Unfavourable step	▼ 13%
Retained profit	€ 20,673 Retained profit 2022: € 20,673 First fiscal year in the series	€ 68,718 Retained profit 2023: € 68,718 ▲ 232% vs 2022 (€ 20,673) Favourable step	€ 165,527 Retained profit 2024: € 165,527 ▲ 141% vs 2023 (€ 68,718) Favourable step	€ 757 Retained profit 2025: € 757 ▼ € 164,770 vs 2024 (€ 165,527) Unfavourable step	▼ € 164,770
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 343,000 Dividend 2025: € 343,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 29,406 Balance sheet total 2022: € 29,406 First fiscal year in the series	€ 93,772 Balance sheet total 2023: € 93,772 ▲ 219% vs 2022 (€ 29,406) Unchanged	€ 206,049 Balance sheet total 2024: € 206,049 ▲ 120% vs 2023 (€ 93,772) Unchanged	€ 200,855 Balance sheet total 2025: € 200,855 ▼ 3% vs 2024 (€ 206,049) Unchanged	▼ 3%

Key figures of DR. CHRISTOPHE SCHOONJANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. CHRISTOPHE SCHOONJANS?

What happened at DR. CHRISTOPHE SCHOONJANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 22, 2025 New annual accounts for financial year 2025: profit of € 178,230 (▲ 84% vs 2024). Source: NBB ↗
Jul 22, 2021 New establishment in Brugge. KBO
Jul 22, 2021 Start of the company according to the CBE. KBO

In short

From € 20,673 profit in 2022 to € 178,230 profit in 2025.

Paid € 103,456 in corporate taxes since 2022.

Best year ever: 2025, with € 178,230 profit.

Paid out € 343,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. CHRISTOPHE SCHOONJANS? We notify you, reason included.

Follow DR. CHRISTOPHE SCHOONJANS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Christophe Schoonjans

DR. CHRISTOPHE SCHOONJANS

Behind DR. CHRISTOPHE SCHOONJANS is Christophe Schoonjans.

See the full network in the app

Directors

According to the 2025 annual accounts

Christophe Schoonjans

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Paallandenstraat 15

8200 Brugge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0771.622.231
VAT number: BE 0771.622.231
Registered office: Paallandenstraat 15, 8200 Brugge
Names & denominations: DR. CHRISTOPHE SCHOONJANS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 July 2021
Peppol: Active · Active since 6 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗